Minerva Surgical to Announce First Quarter 2023 Financial Results
19 April 2023 - 6:01AM
Minerva Surgical, Inc. (Nasdaq: UTRS), a medical technology company
focused on solutions to meet the distinct uterine healthcare needs
of women, announced today that it will release its first quarter
2023 financial results on Tuesday, May 2, 2023. In conjunction with
the release, the company will host a conference call and webcast
that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to
discuss its financial results and recent highlights.
To access the live call via telephone, please register in
advance using the link here. Upon registering, each participant
will receive an email confirmation with dial-in numbers and a
unique personal PIN that should be used to join the call.
The live webinar of the call may be accessed by visiting the
Recent Events section of the company’s website at
http://ir.minervasurgical.com. A replay of the webinar will be
available on the Company’s website shortly after the conclusion of
the call.
About Minerva Surgical, Inc.
Minerva Surgical is a commercial-stage medical technology
company focused on developing, manufacturing, and commercializing
minimally invasive solutions to meet the distinct uterine
healthcare needs of women. The Company has established a broad
product line of commercially available, minimally invasive
alternatives to hysterectomy, which are designed to address the
most common causes of Abnormal Uterine Bleeding (AUB) in most
uterine anatomies. The Minerva Surgical solutions can be used in a
variety of medical treatment settings and aim to address the
drawbacks associated with alternative treatment methods and to
preserve the uterus by avoiding unnecessary hysterectomies.
INVESTOR RELATIONS CONTACT
Caroline Cornerinvestors@minervasurgical.com 415-202-5678
RELATED LINKS
https://www.aubandme.com
https://www.minervasurgical.com
Minerva Surgical (NASDAQ:UTRS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Minerva Surgical (NASDAQ:UTRS)
Historical Stock Chart
From Oct 2023 to Oct 2024